Company intelligence / Profile preview

Via Naturale

Seoul, Seoul, South Korea

Ownership: Private
Employees: ~30
Development stage: Other

Overview

ViaNaturale is a South Korean biopharmaceutical company dedicated to the development of novel therapeutics derived from natural products. Founded by Professor Sun-Young Kim, the company utilizes a sophisticated drug discovery platform to identify and standardize bioactive compounds for chronic inflammatory diseases. Its lead candidate, VN-100, is currently in Phase 2 clinical trials for the treatment of atopic dermatitis, while VN-101 is being evaluated for dry eye syndrome. The company's pipeline also includes programs for asthma, COPD, and hair loss, all leveraging the safety and efficacy profiles of natural substances. ViaNaturale aims to modernize natural medicine by applying rigorous clinical validation and pharmaceutical-grade manufacturing standards.

Therapeutic areas: PulmonologyOphthalmologyDermatology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Via Naturale.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Via Naturale.

Explore the full profile